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The financial impact of production diseases in poultry production systems 13 
 14 
Abstract  15 
Whilst the academic literature widely asserts that production diseases have a significant 16 
financial impact on poultry propduction, these claims are rarely supported by empirical 17 
evidence. There is a risk, therefore, that the information needs of poultry producers 18 
regarding the costs associated with particular diseases are not being adequately met.  19 
 20 
A systematic literature review of poultry production diseases was undertaken, first to 21 
scope the availability of studies that estimate the financial impacts of production diseases 22 
on poultry systems and second, based on these studies, estimates were generated of 23 
the magnitude of these impacts. Nine production diseases, selected by a panel of 24 
stakeholders as being economically important in the EU, were examined.  25 
 26 
The review found that the poultry disease literature has primarily an epidemiological 27 
focus, with very few publications provideing estimates of the financial impacts of 28 
diseases. However, some publications quantified the physical impacts of production 29 
diseases and control interventions, e.g. using measures such as output volumes, 30 
mortality rates, bacteria counts, etc. Using these data in standard financial models, 31 
partial financial analyses were possible for some poultry production diseases.  32 
 33 
Coccidiosis and clostridiosis were found to be the most common production diseases in 34 
broiler flocks, with salpingoperitonitis the most common in layers. While the financial 35 
impact of untreated diseases varied, most uncontrolled diseases were estimated to make 36 
flocks loss-making. However, in all cases, interventions were available that signficantly 37 
reduced these losses. The review reinforces the concern that the available academic 38 
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literature is not providing sufficient information for poultry producers to decide on 39 
financially-optimal disease prevention and treatment measures. 40 
 41 
Keywords: Poultry diseases; financial impacts; systematic literature review. 42 
 43 
1. Introduction 44 
There have been major changes in food consumption patterns in Western countries in 45 
the last 20 years, driven by increasing disposable incomes, changing food tastes and 46 
evolving health concerns (Traill, et al., 2014; European Commission, 2015). While egg 47 
consumption has remained fairly static (FAO, 2016a), there has been substantial 48 
growth in demand for poultry meat. Poultry meat is now the largest single source of 49 
meat-based protein in the diets of some countries, for example constituting 31% of all 50 
meat consumption in the UK and 43% in the USA in 2011 (FAO, 2016b). The chicken 51 
meat sector has responded to this increased demand by intensification of broiler 52 
production systems, involving more vertical integration, increases in production scale, 53 
use of new technologies and higher rates of input use, including higher stocking rates 54 
(FAO, 2016c).  55 
 56 
A negative side of increasing production intensity has been a rise in the prevalence of 57 
so-called ‘production diseases’ in poultry systems. These usually originate from a 58 
complex interaction of pathogens, animal genetics and environment, including 59 
deficiencies in housing, nutrition and management. Production diseases constitute 60 
various infections, but also physical conditions, such as ascites, caused by genetic 61 
developments designed to increase physical performance, and physical damage 62 
caused by objects, or chemical irritants, in the rearing environment. What these 63 
diseases have in common is that, while they may be endemic, even in the wild, they 64 
can become increasingly problematic with the intensity of the production system and 65 
failures in management (Liverani, et al, 2013). 66 
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 67 
Production diseases compromise animal health and welfare and generate production 68 
inefficiencies, which can reduce profitability, and increase both environmental footprint 69 
and levels of antibiotic use. Bennett (2012) has provided a conceptual understanding of 70 
the way in which production diseases impact the economics of poultry production 71 
systems, i.e. through:  72 
1. Economic impacts internal to the farm: 73 
• a loss of capital (i.e. animal mortality); 74 
• reduction in the level of marketable outputs; 75 
• reduction in (perceived or actual) output quality; and  76 
• waste of, or higher level of use of, inputs. 77 
2. Economic impacts both internal, and external, to the farm: 78 
• resource costs associated with disease detection, diagnosis, prevention 79 
and control; 80 
• negative animal welfare impacts (i.e. animal suffering) associated with 81 
disease; 82 
• international trade restrictions due to disease and its control; and 83 
• human health costs associated with diseases or disease control. 84 
3. Economic impacts external to the farm such as effects on rural economies 85 
and tourism. 86 
With producer margins being squeezed by increasing costs and limited opportunity to 87 
transmit extra costs to consumers due to lack of market power, plus fierce competition 88 
from international suppliers, the response of the poultry industry has been to drive 89 
down those production costs that can be controlled, including disease costs (Narrod et 90 
al., 2008). To allow the industry to prioritise the most financially beneficial disease 91 
prevention and control measures, robust empirical data are required on: the risks 92 
posed by various production diseases; the financial impacts of different diseases; and 93 
the efficacy of, and financial benefits from, different disease control measures.  94 
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It might be be assumed that data to permit financially rational disease management 95 
decisions are available in the scientific literature. Much literature on poultry diseases 96 
exists, but data for individual diseases is seldom extensive and often lacking a financial 97 
dimension. Ubiquitous claims in research papers that particular poultry diseases lead to 98 
‘significant’ financial impacts are seldom supported by empirical evidence. 99 
Consequently, data on the scale of financial losses associated with particular 100 
production diseases and the financial case for using control measures, are often 101 
lacking. Therefore, unless more informative industry data is available, there may be 102 
many poultry producers who are not implementing financially optimal disease 103 
prevention and treatment practices through lack of appropriate information. For 104 
example, in Denmark, vaccines are widely used to control salpingoperitonitis infections 105 
in layers without robust evidence of their efficacy (Christensen, 2016). 106 
 107 
The study reported here undertook a systematic literature review to: determine the 108 
availability of data on the financial impacts of poulty production diseases; and a 109 
synthesis of this data to estimate the financial impacts of a number of production 110 
diseases and, where possible, the financial benefits of selected measures to control 111 
them. The study also had three sub-objectives. First, to show the relative risks 112 
presented by different production diseases, from data on their incidence. Second, to 113 
map the nature and distribution of disease costs, by showing where, in the production 114 
process, losses are occurring. Finally, to identify gaps in the literature on the financial 115 
impacts of poultry production diseases, to help guide future research. 116 
 117 
2. Method 118 
2.1 The choice of production diseases 119 
To reduce the scope of the study, the most important production diseases were 120 
selected for analysis by a panel of 29 European animal scientists collaborating on the 121 
EU-funded PROHEALTH project.These came predominantly from veterinary medicine 122 
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or animal science backgrounds. Nine production diseases were identified as the most 123 
important by virtue of rates of incidence, revenue losses, or control problems, i.e. 124 
respiratory diseases (Ascites; Infectious bronchitis), enteric (Coccidiosis; Clostridiosis), 125 
locomotory (Tibial dischrondoplasia; Foot pad dermatitis; Keel bone damage), 126 
reproductive (Salpingoperitonitis) and other disorders (Injurious feather pecking). 127 
 128 
2.2 The systematic literature review -  129 
2.2.1 Introduction 130 
A systematic review was undertaken to identify studies reporting financial or 131 
productivity impacts of these nine production diseases/conditions. As a first step, a 132 
Web of Science search was undertaken using a tailored search term with keywords to 133 
capture:  134 
(i) economic (or financial) studies; 135 
(ii) poultry as study subjects;  136 
(iii) specific production diseases; 137 
(iv) exclusion of topics appearing in searches but not relevant to the review;  138 
(v) exclusions to remove studies based on non-intensive production systems; 139 
and 140 
(vi) exclusions by text language, research domain, document type and 141 
publication prior to 1995.  142 
 143 
Abstracts found through the search were examined to exclude: duplications, those with 144 
no physical performance measures or financial data, or were based on modelling 145 
studies or reviews. This yielded 64 original studies. To supplement this list, additional 146 
publications were found by: reviewing the reference lists of publications already 147 
identified; a secondary web search using Google Scholar; website searches of 148 
organisations with an interest in poultry health, such as the FAO; and reference lists 149 
from recent poultry health research projects. This secondary search yielded a further 150 
 Animal Production Science | Jones, et al 2018 
 
7 
 
65 studies, making 129 in total. These publications encompassed peer-reviewed 151 
journals and conference proceedings, as well as ‘grey’ literature. Few publicatons 152 
assessed financial impacts, with most falling into the three categories shown in 153 
Sections 2.2.2 through 2.2.4.  154 
 155 
2.2.2 Surveys of disease invidence and severity 156 
A few studies surveyed the incidence of production diseases. Incidence, which is the 157 
number of (new) disease incidents (or outbreaks) over a specified period of time, can 158 
be viewed as an indicator of risk. Incidence might be reported for a particular flock, or 159 
as an average across flocks (e.g. average annual incidence). In the studies reviewed, 160 
flocks were generally only deemed to have experienced a disease outbreak when 161 
symptoms met a given severity criterion i.e. they either exhibited clinical symptoms, or 162 
where subclinical disease resulted in fiancial impacts. As we were only interested in 163 
disease episodes that cause financial losses, the analysis of incidence here was limited 164 
to those surveys where this criterion was explicitly used.   165 
 166 
2.2.3 Studies exploring the impact of uncontrolled diseases on production  167 
In this type of experimental study, birds could be deliberately exposed to a disease in 168 
either a controlled, or uncontrolled way. In the latter case, ambient levels of disease 169 
prevailed and therefore disease prevalence or severity was sometimes not elevated at 170 
all. Some of these studies employed a protected (or disease free) control group, while 171 
others did not.  172 
 173 
2.2.4 Studies exploring the efficacy of measures to control production diseases  174 
Intervention studies were the most common type of study in the reviewed literature. 175 
These involved trials of wide-ranging scale, from a few dozen birds to tens of 176 
thousands of birds across many poultry businesses. These studies had a variety of 177 
formats, depending on the: 178 
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• presence of a control group; 179 
• presence of replicates; 180 
• the number of interventions tested; and  181 
• the level of control of environmental (rearing) conditions.  182 
Studies with no control groups were excluded from the assessment. Where there were 183 
replicates of trials, averages over the replicates were calculated. When multiple, 184 
similar, interventions were used, for example several types of vaccine, an average over 185 
these interventions was taken. When multiple interventions were very different, for 186 
example contrasting a vaccine against a dietary nutrient, they were treated as separate 187 
interventions. When studies manipulated environmental conditions, in addition to target 188 
interventions, such as wetness of litter, then an average for the intervention over the 189 
multiple environmental conditions was estimated. 190 
 191 
2.3 The standard financial models 192 
Because financial data were rarely provided, the costs of diseases were estimated from 193 
data on changes to productive parameters (i.e. FCR, mortality and output volumes), 194 
using spreadsheet-based standard financial models for poultry enterprises. These were 195 
based on published data for market returns and production costs for EU ’average’ 196 
conventional broiler and layer enterprises for 2013 (Appendix A).  197 
 198 
2.5 Weighting of data 199 
Recognizing that greater confidence can be placed on trials conducted on larger 200 
populations of birds, a weighting system was used in estimating averages across 201 
replicate trials. As studies often didn’t state the exact number of birds in a trial, the 202 
value of the weights increases with size ranges using a geometric progression with a 203 
common ratio of two. By this means, data from experiments with up to 1,000 birds were 204 
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given a weight of one, 1,001-10,000 birds had a weight of two, 10,001-25,000 birds a 205 
weight of four, and more than 25,000 birds a weight of eight. 206 
 207 
3. Results 208 
3.1 The number of relevant studies identified from the systematic literature review 209 
Table 1 lists the number of relevant studies identified for the nine study production 210 
diseases, classified by the type of intervention used. Studies reporting no interventions 211 
in Table 1 either examined the impacts of the uncontrolled disease, or were surveys of 212 
disease incidence.  213 
 214 
Table 1. The number of publications found reporting the impacts of poultry production 215 
diseases and/or impacts of interventions to control them. 216 
 
 
 
 
Type of prevention/control intervention  
 
Total 
studies2 
 
None 
Anti-
microbials1 
 
Vaccination 
 
Housing 
 
Other3 
Respiratory diseases  
     
Pulmonary hypertension syndrome 
(ascites) 
1  -  -  - 9 10 
Infectious bronchitis (IB) 14  -  5  - - 19 
Enteric diseases  
     
Coccidiosis 1  7 8  -  - 16 
Clostridiosis (C. perfringens, C. 
septicum) 
1 10 3  - 1 15 
Locomotory diseases  
     
Tibial dischrondoplasia 3  -  - 4 7 14 
Foot pad dermatitis 3  -  -  - 12 15 
Keel bone damage 10  -  -  3 5 18 
Reproductive disorder  
     
Salpingoperitonitis syndrome, 
(colibacillosis)  
9 1  -  -  - 10 
Other disorders  
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Injurious feather pecking 7  -  - 4 1 12 
Total 45 18 16 11 35 129 
 217 
1 For either prophylactic or curative treatment. 218 
2 Some studies had multiple interventions, so the total number of studies may not equal the number of 219 
interventions. 220 
3 ’Other’ usually involves changing parameters in the rearing environment, such as temperature, or 221 
humidity. 222 
 223 
3.2 Disease incidence 224 
This data came from studies ranging from large-scale surveys to small-scale laboratory 225 
trials. Because of the dominance of small-scale studies in the literature, the estimates 226 
in Table 2 should be treated with caution. Coccidiosis and clostridiosis would seem to 227 
be present in 90 - 100% of poultry flocks (Williams, 1998; Miller et al., 2010). There is a 228 
far greater incidence of the subclinical forms of these diseases, but these are only 229 
included in the incidence estimates where they cause productivity losses. The lowest 230 
reported disease incidence (at 5%) was reported for ascites, but most production 231 
diseases appear to have a reported incidence of over 30% of flocks. 232 
 233 
Table 2.  The incidence of production diseases and sources of this data 234 
 Incidence 
(% of flocks) 
 
Sources of data 
Ascites 
B
ro
ile
r 
fl
o
c
k
s
 
5 Hassanzadeh et al. (2005); Hassanzadeh et al. (2008); 
Maxwell and Robertson (1998) 
Coccidiosis 90-100 Williams (1998, 1999)1 
Clostridiosis 90-100 Miller et al. (2010)1 
Footpad 
dermatitis 
41.1 Allain et al. (2009); de Jong et al. (2014); Pagazaurtundua 
and Warriss (2006) 
Tibial 
dyschondroplasia 
35.6 
 
Edwards (1990); Edwards and Sorensen (1987); Leeson et 
al. (1995); Lilburn and Lauterio (1989); Lui et al. (1992); 
Petek et al. (2005); Trablante et al. (2003); Yalcin et al. 
(2007) 
Salpingoperitonitis L a y e r s
 49.5 Fossum et al. (2009)2 
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Injurious feather 
pecking 
35 Lambton et al. (2013) 
 235 
1 Exact estimates of incidence for coccidiosis and clostridiosis are unavailable but sources indicate these 236 
infections are close to ubiquitous. 237 
2 Estimate of incidence of coliobaccilosis i.e. e-coli infections. 238 
 239 
3.3 Mortality rates 240 
Financial impacts resulting from elevated bird mortality comes from: loss of sales; 241 
expenditure on housing, feed and health care for birds that subsequently die; and the 242 
cost of disposal of carcasses. Once a disease is present in a flock, mortality rate is 243 
determined both by the severity of the disease challenge, and other factors such as the 244 
type of bird, breed, age at end of productive life-cycle and housing and production 245 
system, e.g. free-range. In an average commercial setting, with ’standard’ disease 246 
management practice, cumulative mortality in layers, from all causes, ranges from 6 -  247 
11%, with an average of 7.7% (van Horne, 2014; Weber et al., 2003; Merle et al., 248 
undated; Vitse et al., 2005; and Bell, 2012). Cumulative mortality in broilers is 249 
somewhat lower, ranging between 4 - 6% with an average of 4.7% (Havenstein et al., 250 
2003; ACP, 2006; Gocsik et al., 2014; and van Horne and Bont, 2014). Table 3 shows 251 
the change in rate of mortality resulting from uncontrolled production diseases that are 252 
classified in studies as severe, i.e. where they have measureable financial impact. Also 253 
shown are the ranage of mortality values (in parentheses) found in the literature, where 254 
more than one usable estimate is available. 255 
 256 
Table 3.   Impact of severe uncontrolled production disease on flock mortality rates 257 
 
 
Mortality 
change (%) 
(range %) 
 
Sources of data 
Broilers   
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Tibial 
dischondroplasia 
+1 Morris (1993) 
Acites +36.3 
(15.2 – 68) 
Acar et al. (1995); Arce-Menocal et al. (2009); Camacho-
Fernandez et al. (2002); Izadinia et al. (2010) 
Clostridiosis +336 
(45.4 – 1500) 
Lovland and Kaldhusdal (2001); Miller et al. (2010);Tactacan et al. 
(2013); Zhang et al. (2010) 
Footpad 
dermatitis 
+12.7 
(-1 – 87.5) 
Bilgili et al. (2009); Cengiz et al. (2011); de Jong et al. (2014); 
Ekstrand et al. (1997); Martland (1985); Mayne et al. (2007); Taira 
et al. (2013); Wang et al. (2010) 
Laying flocks   
Keel bone 
damage 
+71.5 
(65.1 - 77.8) 
Nasr et al. (2013); Petrik et al. (2015); 
Salpingoperitonitis +57 Jordan et al. (2005); Medina (2008), Thøfner et al. (2015) 
 258 
Note: Change in mortality is the change to the base, or ’normal’, mortality rate resulting from uncontrolled 259 
disease. 260 
Note: Coccidiosis, Salpingoperitonitis and Injurious pecking are omited from the table due to lack of data. 261 
 262 
Mortality impacts vary considerably between, and within, production diseases, and 263 
disease-driven mortality rates much higher than those in Table 3 have been observed 264 
in commercial practice. However, the headline observation is the paucity of studies on 265 
the mortality impacts of specific diseases in the literature. This problem is compounded 266 
by methodological weakness that affect the available data, i.e. some studies either 267 
have no experimental control, or they have a disease-challenged control, rather than a 268 
true (disease free) control. The lack of robustness in the available data is exemplified 269 
by the mortality impacts estimated for keel bone damage, which are considerably 270 
higher in the studies cited  than have been observed by the authors in commercial 271 
farming practice.  272 
 273 
3.4 Loss of physical outputs 274 
Production diseases can lead to financial losses through reductions in the physical 275 
output from flocks (see Table 4). In broilers this can take the form of reduced terminal 276 
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weight (or rather, a longer growing period to reach the desired weight, requiring more 277 
feeding and less efficient utilization of resources). In layers this would mean reduced 278 
egg numbers, but also impairment of output quality. Loss of quality in broilers means 279 
broken bones, damaged or discoloured muscle, or skin burns, leading to carcass 280 
downgrades, or trimmings. In layers, this is experienced as smaller or mishapen eggs, 281 
thin shells and colour change, resulting in downgrades or rejections.  282 
 283 
Reviewed studies report reductions in terminal body weight in broilers range from zero 284 
for ascites (although Swayne, 2013, suggests some weight loss is possible), to a high 285 
of 17.7% for coccidiosis. There is a relatively high reported loss of body weight from 286 
tibial dyschondroplasia. This effect is likely due to the fact that the condition can cause 287 
considerable pain, and birds in pain move less and consume less food.  288 
 289 
Table 4.  Impact of severe and uncontrolled production disease on physical outputs 290 
Broilers Live- 
weight (% 
change) 
(range) 
Carcass downgrades 
(% change) 
(range) 
Sources of data 
Tibial 
dischondroplasia 
-10 <1 Burton et al. (1981); Edwards and 
Sorensen (1987); Morris (1993) 
Acites 0 N.A. Acar et al. (1995); Arce et al. (1992); 
Arce-Menocal et al. (2009); Camacho-
Fernandez et al. (2002); Izadinia et al. 
(2010); Kalmar et al. (2013); Khajali et 
al. (2007); Maxwell and Morris (1992); 
Rincon (2000); Robertson (1998) 
Clostridiosis -1.24 
 
N.A. Lovland and Kaldhusdal (2001) 
Coccidiosis -17.7 
(-17.3 - -18.1) 
N.A. Abdelrahman et al. (2014); Li et al. 
(2005) 
Footpad 
dermatitis 
-7.3 
(0.8 – -14.6) 
<1 Cengiz et al. (2011); de Jong et al. 
(2014); Martland (1985)  
Laying Flocks Egg 
numbers 
Egg weight Egg 
quality 
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Keel bone 
damage 
-3.5 
(-1.2 - -5.7) 
-3.2  Nasr et al. (2012); Nasr et al (2013) 
Infectious 
bronchitis 
-32.9 
(-3 - -50) 
-8.7 
(-7.3 - -11.36) 
N.A. Bisgaard M. (1976); Muneer et al. 
(1986); Muneer et al. (1987); Ignjatovic 
and Sapats (2000); Muneer et al. 
(2000) 
Salpingoperitonitis N.A. N.A. <1 Bisgaard and Dam (1981) 
Injurious feather 
pecking 
-5.1 
(-2.6 - -7.5) 
0 0 Glatz (2001); Hagger et al. (1989); 
Peguri and Coon (1993); Leeson and 
Morrison (1978) 
Note: N.A. means that suitable data are not available. 291 
 292 
Disease impacts on laying flocks (number of eggs) rangese between 3.5% and 32.9%, 293 
although greater losses may be observed in commercial practice. The impact of keel 294 
bone damage and injurious pecking on egg production should be low, unless birds 295 
contract secondary infections. In the case of feather pecking, feather loss means 296 
elevated loss of body heat, so that birds must eat more food to regulate body 297 
temperature and continue normal egg laying. While the impacts of infectious bronchitis 298 
can be severe, these effects last for only a small part of the productive life of a hen, 299 
typically 1-8 weeks. If a disease does not kill a hen, it will recover, and so, typically, will 300 
the laying percentage, although productivity may not always recover to pre-disease 301 
levels (Ignjatovic and Sapats, 2000; and Bisgaard, 1976). Based on available data, 302 
infectious bronchitis has the most significant impact on egg downgrades. 303 
 304 
3.5 Impaired feed conversion ratio 305 
All production diseases, if severe enough, impair birds’ FCR i.e. they lower feed 306 
conversion efficiency. Where the bird cannot compensate by eating more, this can lead 307 
to loss of physical output. Where additional food is available and the bird has the 308 
capacity to consume it, physical outputs need not be reduced, but financial losses will 309 
still be experienced due to elevated feed consumption. Reductions in FCR ranged from 310 
zero for ascites to reductions of 25.9% for severe feather pecking (Table 5).  311 
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 312 
Table 5. Impact of severe, uncontrolled, production disease on the feed conversion 313 
ratio (FCR) 314 
 
 
Reduction in 
FCR (%) 
(range) 
 
Sources of data 
Broilers   
Acites 0 Acar et al. (1995); Arce et al. (1992); Arce-Menocal et al. (2009); 
Camacho-Fernandez et al. (2002); Izadinia et al. (2010); Kalmar et al. 
(2013); Khajali et al. (2007); Maxwell and Robertson (1998); Morris 
(1992); Rincon, (2000) 
Clostridiosis 16.4 
(-3.7 – 70.5) 
Lovland and Kaldhusdal (2001); Miller et al. (2010); Tactacan et al. 
(2013); Zhang et al. (2010)  
Coccidiosis 17.7 Abdelrahman et al. (2014); Li et al. (2005) 
Footpad 
dermatitis 
3.3 
(1.06 – 4.35) 
Cengiz et al. (2011); de Jong et al. (2014)  
Laying flocks   
Injurious feather 
pecking 
25.9 
(-5.1 - -49.7) 
Glatz (2001); Leeson and Morrison (1978); Peguri & Coon (1993) 
Note: Suitable data are not available for Tibial Dischondroplasia, Keel bone damage, Infectious bronchitis 315 
and salpingoperitonitis. 316 
 317 
 318 
3.6 Financial impacts of uncontrolled production diseases 319 
The financial impacts of these diseases were estimated by applying percentage 320 
changes in physical outputs to the standard broiler and layer financial models 321 
(Appendix A). On the few occasions where data were available from the studies on 322 
changes to input costs resulting from the diseases, or interventions, these were also 323 
used in the financial models. For six of the diseases there were sufficient data to 324 
undertake financial analyses, while for three there were not. In Figures 1 and 2, the 325 
darker shaded bars represent the financial losses per bird, averaged over the flock, 326 
arising from the uncontrolled diseases and the lighter bars show the losses that would 327 
be incurred after applying the best available interventions to control them. Not 328 
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surprisingly, average losses for layers are higher than broilers because layers have a 329 
longer productive life (around 56 weeks (RSPCA, 2016) and thus generate more 330 
revenue. Broilers are usually slaughtered around 6-7 weeks in the EU and USA (EFSA, 331 
2010; National Chicken Council, 2016), depending on growth rates and desired 332 
slaughter weights.  333 
 334 
Uncontrolled clostridiosis caused the greatest reported losses, at around €0.32 per bird 335 
averaged over the flock, while losses from uncontrolled coccidiosis amounted to €0.21 336 
per bird. Based on the financial model used here, confirmed by anecdotal industry 337 
evidence, the net (profit) margin for a typical commercial broiler enterprise in the EU in 338 
2013 was low, at around 10 Euro Cents per bird. With margins as tight as this, all of the 339 
production diseases costed here would, when unconstrained, make affected flocks 340 
loss-making.  341 
 342 
Based on the standard financial model, laying hens typically generated a margin of 343 
around €6 per bird in 2013. Figure 2 shows that, among the studied diseases, keel 344 
bone damage causes the largest financial losses in laying hens, at around €3.5 per bird 345 
averaged over the flock. However, this result should be treated with some caution in 346 
view of the doubts raised above over the scale of mortality losses reported for this 347 
disease.  348 
 349 
A number of possible disease costs have not been accounted for, due to lack of data. 350 
Typically, there are no data available from most disease impactstudies on labour, vet 351 
and medicine costs, additional carcass disposal costs, or costs associated with the 352 
disruption of normal husbandry practices resulting from diseases, such as delays to 353 
thinning and depopulation to allow extra time for broilers to reach target weight. Also 354 
not reported are losses from increased heterogeneity of broiler weights in a cohort, 355 
meaning that a greater proportion of birds would fail to meet buyer requirements for 356 
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permissible weight range and would have to be sold at lower prices, often through 357 
alternative marketing channels. 358 
 359 
Figure 1.  Financial losses due to four production diseases (controlled and uncontrolled) in 360 
broiler flocks. 361 
 362 
  363 
 364 
Figure 2. Financial losses due to two production diseases (controlled and uncontrolled) in 365 
laying flocks. 366 
 367 
 368 
3.7 The efficacy of interventions 369 
Interventions to control production diseases in poultry are of two types, both adding to 370 
production costs: treatment and prevention measures. Once a disease outbreak has 371 
occurred, producers react with one or more courses of treatments, often with veterinary 372 
support. Because many diseases are endemic, and difficult or expensive to control 373 
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once established, producers sometimes deploy preventive measures to try to reduce 374 
the risk of outbreaks and/or their severity. The cost of therapeutic treatments can be 375 
reduced if treatment begins early in a disease outbreak and so, producers may also 376 
increase expenditure on health monitoring to identify early signs of disease.  377 
 378 
As Table 6 shows, many types of intervention have been evaluated in the literature, 379 
although there are few studies for any particular intervention. There is some 380 
heterogeneity within type of intervention studied for each disease. For example, in the 381 
anti-microbial category, treatments might be dietary supplements, probiotics, 382 
bacteriophage therapy, or antibiotics, with variation within these categories based on 383 
compounds or brands used, and concentrations of active ingredients. The data 384 
presented in Figures 1 and 2 represent the single most efficacious intervention 385 
reported in the literature for each disease. These estimates provide a sense of the 386 
higher end of the achievable levels of control that might be expected in a commercial 387 
setting.  388 
 389 
Figures 1 and 2 show that there are considerable differences between these diseases 390 
in terms of both the financial losses caused when uncontrolled, and the extent to which 391 
interventions can reduce these losses. Tibial dyschondroplasia, for example, causes 392 
relatively small financial losses, but these are relatively difficult to eliminate. 393 
Conversely, diseases such as clostridiosis and infectious bronchitis, while resulting in 394 
very high financial costs when uncontrolled, can be reduced effectively through 395 
interventions. The diseases that would seem most problematic are those, such as keel 396 
bone damage, which lead to high financial costs when unconstrained and which resist 397 
attempts to control them. Based on this analysis, coccidiosis appears to fall into this 398 
class, with lower efficacy of interventions than for other diseases. However, producers 399 
report that both vaccines and anti-microbials offer significant means of disease control 400 
in a commercial setting.  401 
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 402 
Table 6. Types of intervention to control production diseases from the literature review. 403 
 Class of 
measure 
Types of intervention and data sources 
Broilers   
Tibial 
dischondroplasia 
Prevention  Manipulation of nutrients (Edwards, 1990)  
Manipulation of feed consumption (Edwards and Sorensen, 1987; 
Onbasilar et al., 2007)  
Manipulation of egg incubation temp. (Yalcin et al., 2007)  
Acites Prevention Feed restriction – full rearing period (Arce et al. 1992; Camacho-
Fernandez et al., 2002; Rincon 2000) 
Feed restriction – early weeks (Acar et al., 1995; Arce et al., 1992; 
Khajali et al., 2007)  
Clostridiosis Treatment Antibiotics (Tactacan et al., 2013; Zhang et al., 2010)  
Bacteriophage therapy (Miller et al., 2010)  
Other antimicrobials (Tactacan et al., 2013)  
Coccidiosis Prevention Vaccines (Lee et al., 2009; Li et al., 2005; Miguel et al., 2008; Shirley et 
al., 1995; Sou et al., 2006; Vermeulen et al., 2001; Williams et al., 1999; 
Williams and Gobbi, 2002)  
Probiotics (Abdelrahman et al., 2014)  
Herbal treatments (Miguel et al., 2008)  
Anticoccidials (Abdelrahman et al., 2014; Lee et al., 2009; Li et al., 2005; 
Miguel et al., 2008; Sou et al., 2006; Williams et al., 1999; Williams and 
Gobbi, 2002)  
Footpad 
dermatitis 
Prevention Manipulation of litter moisture (Cengiz et al., 2011; de Jong et al., 2014; 
Ekstrand et al., 1997; Martland, 1985; Mayne et al., 2007; Taira et al., 
2013; Wang et al., 2010)  
Variation of litter materials (Bilgili et al., 2009)  
Laying flocks   
Keel bone 
damage 
Prevention Switch from unenriched to enriched cages (Petrik et al., 2015; Sherwin 
et al., 2010; Wilkins et al., 2011)  
Infectious 
bronchitis 
Prevention Vaccines (Cook et al., 1999; Faramarzi et al., 2014; Jones et al., 2005; 
Tarpey et al., 2006; Tawfik et al., 2013)  
Salpingoperitonitis Prevention Probiotics (Shini et al., 2013) 
Inoculation (Reid and Bocking, 2003) 
Vaccination (Gregersen, et al., 2010) 
Treatment Antimicrobials (Balevi et al., 2001; Nahashon et al., 1996; Willis and 
Read, 2008) 
Injurious feather 
pecking 
Prevention Housing (Fossum et al., 2009)  
Beak trimming (Craig and Lee,1990)  
Enriched environment (El-Lethey et al., 2000; Lambton et al., 2013)  
Reduced stocking rates (Nicol et al., 1999)  
Feed modification (Ambrosen and Petersen,1997) 
 404 
 405 
There are two possible explanations for the discrepancy between the results of the 406 
scientific trials and real-world experience. First, that the few studies available are 407 
simply generating unrepresentative results and, second, and perhaps more likely, that 408 
the reviewed studies are capturing sub-clinical disease impacts. Observation of 409 
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commercial practice suggests that coccidiostats, such as ionophore antibiotics, while 410 
effective at controlling clinical disease, are seemingly less effective at controlling 411 
subclinical impacts, leading to losses through reduced feed intake and feed conversion 412 
efficiency (Christensen, 2016). 413 
  414 
4. Discussion 415 
Our study found that there is an almost complete absence of published  studies 416 
generating data on the financial impacts of these nine poultry production diseases. 417 
Generalising from this, it might be supposed that the entire poultry disease literature 418 
has very much an epidemiological, rather than financial, focus.  419 
 420 
To estimate the financial impacts of the nine poultry production diseases, and control 421 
interventions, it was necessary to apply data on changes to productive parameters to 422 
standard financial models (for broilers and layers) in order to monetise them. However, 423 
there are significant gaps, even in the data on the impacts of diseases on productive 424 
parameters, a case in point being salpingoperitonitis, where there are insufficient data 425 
to permit any estimation of financial impact. This is perhaps explicable in view of the 426 
tendency for salpingoperitonitis to occur in conjunction with other E. Coli-induced 427 
conditions, such as airsaculitis, and secondary infections such as septicemia. 428 
 429 
There is great heterogeneity of research objectives and methodology in the reviewed 430 
studies, with some focusing on disease incidence, others on disease severity, others 431 
seeking to capture the physical impacts of the disease itself, while others are 432 
concerned only with the efficacy of control interventions. As a consequence of this, 433 
together with the few studies, there is little or no replication in the literature and, 434 
sometimes, essential data are only available from a single study. This limitation affects 435 
the level of confidence that can be placed in the available data when generalising to 436 
the whole sector.   437 
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 438 
The lack of focus on finanial impacts in studies means that, even if data on changes to 439 
productive parameters are available and can be monetised, impacts on some cost 440 
categories, such as vet and medicine costs, still cannot be captured. With very little 441 
data on the impact of production diseases on the quality of outputs, the full financial 442 
impact of downgrades to carcasses or eggs cannot be accounted for, and so disease 443 
impacts may be underestimated. The lack of data on the cost of interventions means 444 
that the estimates of the financial savings resulting from using them may be over-445 
estimated in our study.  446 
 447 
Different studies often show a wide range of severity of impacts for the same disease. 448 
More extreme impacts than estimated here might occur in commercial practice for a 449 
number of reasons, including variations in: rearing environment; breed; management 450 
quality; and the pathogenicity of infections. An additional cause of variation is the 451 
occurrence of secondary infections. Most studies do not report  data where secondary 452 
infections are known to have occurred, on the grounds that such data would bias 453 
impact estimates for the individual production diseases themselves. However, it must 454 
be acknowledged that part of the set of negative consequences arising from the 455 
occurrence of production diseases is an elevated risk of secondary infections from 456 
other diseases.  457 
For the reasons identified above, it is concluded that there are deficiencies in the 458 
literature (and in the underlying reported research) resulting in data which are difficult 459 
to use. Thus, the financial impacts estimated for the production diseases examined 460 
here should be treated with some caution. Despite this, the claims made by many 461 
authors in the poultry disease literature that production diseases can have significant 462 
financial impacts would appear correct, even though these authors seldom supply any 463 
empirical financial evidence supporting these claims.  464 
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 465 
While poultry farms with elevated levels of production diseases can make substantially 466 
less profit than farms with low disease levels, these losses can be significantly reduced 467 
by a range of prevention measures, such as vaccinations, or improved litter 468 
management, nutrition and hygiene, as well as curative treatments. The financial 469 
benefits of interventions to control production diseases vary greatly according to 470 
disease and the intervention chosen. The losses associated with diseases such as 471 
clostridiosis, for example, can be significantly reduced through use of antimicrobials, 472 
but others, such as keel bone damage, present a greater challenge.  473 
 474 
The reliance of the poultry industry on the use of antimicrobials to control infectious 475 
diseases highlights the risks to the financial sustainability of the sector from the 476 
continuing growth in farm bacterial reservoirs with resistance to antimicrobial 477 
treatments (Aminov and Mackie, 2007; Sykes, 2010, EFSA and ECDPC, 2016).  478 
 479 
These risks occur on three fronts. First, some antibiotics commonly used for the 480 
treatment of diseases may lose their efficacy. Second, government action plans, such 481 
as the EU Action Plan Against the Rising Threats from Antimicrobial Resistance (EU, 482 
2011), which are designed to drive more responsible use of antibiotics, may make 483 
some antibiotics less readily available. Third, although there have been few official 484 
bans on the use of selected antibiotics so far, such as the US ban on Fluoroquinolones 485 
(FDA, 2005), governments may adopt the ’precautionary principle’, and issue complete 486 
bans on the use of some antibiotics. 487 
 488 
5. Conclusions 489 
In light of this growing threat, there is a pressing need for the poultry research 490 
community to help identify cost-effective alternatives to antibiotics which offer similar 491 
levels of disease control. These could include: novel substances to strengthen the 492 
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poultry immune response to bacterial infection; naturally occurring bacteriophages; 493 
novel vaccinations; and enhanced biosecurity measures on farm. Although some 494 
rigorous individual studies of alternative approaches have been undertaken, there is 495 
insufficient data across the literature to evaluate them. Failure to develop these 496 
alternatives could significantly, and negatively, impact the future financial sustainability 497 
of the global poultry industry.  498 
 499 
There are strong hints in the literature that some interventions, particularly in relation to 500 
biosecurity measures, reduce disease incidence, prevalence and severity, for multiple 501 
production diseases simultaneously. The use of single interventions to control multiple 502 
diseases would be very advantageous for an industry faced with small profit margins, 503 
volatile markets, and the possibility of further regulation. The industry would, therefore, 504 
benefit from a more holistic effort from the research community to identify the most 505 
useful and cost-effective multi-functional interventions to reduce disease-related 506 
financial losses. 507 
 508 
The analysis above has revealed a disconnect between the requirements of the poultry 509 
industry for data on the financial impacts of diseases and control measures and the 510 
goals of researchers in the non-commercial poultry disease research community.  As a 511 
consequence, the value of such research, even if it targets relevant production 512 
diseases and interventions, is of less value than it could be. In view of this, the question 513 
might reasonably be asked, where are commercial producers and their advisors getting 514 
the data on which to plan their disease management programmes? 515 
 516 
In order to meet the future informational needs of the poultry industry, the focus of 517 
academic poultry disease research needs to be changed. Studies need to generate 518 
data not only on the first-order physical impacts of production diseases, but also 519 
secondary and financial impacts, as is currently already being achieved commonly in 520 
 Animal Production Science | Jones, et al 2018 
 
24 
 
research on pig and dairy cow diseases. This means collecting data from abbatoirs on 521 
the impact of diseases on product quality, as well as data from farm trials and lab-522 
based experiments on changes to the levels of input use resulting from diseases and 523 
the interventions to control them. This would require a more inter-disciplinary approach 524 
to research, involving not just veterinarians or animal scientists, but also agricultural 525 
economists. 526 
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Appendix A.  Standard financial models for broiler and layer enterprises, 2013 957 
  Broilers Layers 
 
Sales: 
Revenues (€/ 100 
kg live weight) 6 
Revenues (€ / 
hen) 6 
Broilers, (2.276 g of meat per bird 
at €107.7/100 kg liveweight);  
Layers, 340 eggs at €7.6/100 
eggs 7  
 
107.7  
 
 
25.84 
Spent hens - 0.36 
 
Expenditure: 
Production costs 
(€/ 100 kg live 
weight) 10 
Production costs 
(€ / hen) 8, 9 
Day old chicks / pullets (17 
weeks) 
15.20  3.30 
Mortality1  2.02  0.87 
Feed  67.00  10.29 
Medication, 5 1.40  0.09 4 
Heating and electricity  2.20   
1.41 4 Water  0.60  
Litter (incl. cleanout & disposal)  3.70  
Labour  3.40  1.10 
Housing 2  6.40  2.75 
General 3  1.00  0.41 
Total costs  102.92  20.22 
Net margin 4.74  5.98 
 958 
1 Mortality costs assumed to be 50% of total rearing costs per dead bird. Mortality rate 959 
for layers assumed to be 9%. 960 
2 Housing costs includes: poultry house and inventory. 961 
3 General costs include: insurance, office, consultancy, telephone, transport.  962 
4 Medication, heating and electricity, water and litter costs are equated with the 'Other 963 
variable costs' category of Van Horne (2014), which includes: heating, electricity, litter, 964 
animal health and catching.  965 
5 Medication costs for broilers taken from Cocsik et al. (2014); layers from RBR (2014). 966 
6 2013 broiler meat and egg prices; Eurostat Median of EU28 prices (authors’ own 967 
calculations) 968 
http://ec.europa.eu/eurostat/statistics-969 
explained/index.php/Agricultural_accounts_and_prices 970 
 Animal Production Science | Jones, et al 2018 
 
41 
 
7 Number of eggs produced per housed bird = 340 (source: van Horne, 2014), based 971 
on enriched cage system).  972 
8 Sources: Van Horne (2014); Agro-Business Consultants Ltd (2012); RBR (2014). 973 
9 2013 prices (based on 2010 (Van Horne, 2014) prices adjusted for inflation using 974 
annual GDP deflators for the EU. Source: World Bank National Accounts Data & OECD 975 
National Accounts files 2010-2015) 976 
10 Sources: Van Horne (2014); Agro-Business Consultants Ltd (2012). 977 
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